Weight Loss & Peptides

Subcutaneous injection

Semaglutide Injection

An FDA-approved semaglutide injection product for long-term weight management in eligible patients, alongside a reduced-calorie diet and increased physical activity.

$77.00 – $98.00 per unit

Oral tablet

Semaglutide Tablets

An FDA-approved oral semaglutide tablet product for long-term weight management in eligible adults, alongside a reduced-calorie diet and increased physical activity.

Subcutaneous injection

Tirzepatide Injection

An FDA-approved tirzepatide injection product for long-term weight management in eligible adults, alongside a reduced-calorie diet and increased physical activity.

$115.12 – $152.95 per unit

Extended-release oral capsule

Phentermine / Topiramate

An FDA-approved combination of phentermine and extended-release topiramate for long-term weight management in eligible patients, alongside diet and physical activity.

$1.10 per unit

Oral capsule

Phentermine

FDA-approved phentermine capsules for short-term use as an adjunct to a weight-reduction regimen in eligible adults. Suitability and duration are determined by the prescriber.

$0.66 per unit

Subcutaneous injection

Tesamorelin

FDA-approved tesamorelin medicine for excess abdominal fat in adults with HIV-associated lipodystrophy. It is not an approved general weight-loss or anti-aging treatment.

$104.50 – $115.00 per unit

Subcutaneous injection

Bremelanotide (PT-141)

FDA-approved bremelanotide medicine for acquired, generalized hypoactive sexual desire disorder in eligible premenopausal women. It is not approved for weight loss or male sexual performance.

$88.00 per unit

Subcutaneous injection

Elamipretide (SS-31)

FDA-approved under accelerated approval to improve muscle strength in patients with Barth syndrome who meet the label criteria. This is a condition-specific medicine, not an approved general wellness or weight-loss treatment.

$104.50 per unit